IAVI Report Online Archives

Listed by issue/date.
2008
2007
2006
2005
2004
2003
2002
  - Vol. 9 (2), Apr. - Jun. 2005. Warming Trends at Keystone Vaccine Conference
World Economic Forum Discusses Global AIDS Vaccine Delivery
IAVI Announces Vaccine Partnership with Swedish Company
France's AIDS Vaccine Program
Licensing an AIDS Vaccine in Developing Countries
AIDS Vaccine Symposium at Barcelona
Vaccine Briefs
  - Vol. 6 (1), Jan. - Feb. 2002. NIH Drops Plans for Phase III Trial
African Vaccine Initiatives
US Army AIDS Vaccine Program Transferred to NIH
New Head for South Africa's Vaccine Program
Barcelona Vaccine Events
Mumbai Meeting Surveys AIDS in India
Vaccine Briefs
2001
  - Vol. 5 (10), Oct. - Dec. 2001. AIDS and vaccine development in Asia
VaxGen's Phase III Trial: Working with a Drug User Cohort
Thailand Prepares for a New Phase III Trial
New in the Pipeline: Australia's Prime-Boost Vaccines
Thailand, AIDS and Vaccines
Viewpoint: HIV Vaccine Development Needs More Focus and Closer
       Collaborations
Helping Pediatric Vaccines Grow Up
AIDS Vaccines 2001: Meeting Briefs
HVTN Plans for Phase III Prime-Boost Trial
Brazil Hosts Meeting for Latin American AIDS Advocates
Industry Insider
IAVI News
Vaccine Briefs
  - Vol. 5 (8), Jul. - Sep. 2001. Special report: Women and AIDS vaccines
AIDS Vaccines and HIV Transmission via Breastfeeding
Holding HIV at Bay: What Keeps Exposed Babies Uninfected?
Women and HIV in Kenya
Closing In On Immune Protection in the Women of Pumwani
HLA Genes and Immunity
Exposed Sero-negative Cohorts
Possibly, A Vaccine Against Herpes—But For Women Only?
High-Risk Women in a New York Phase III Trial
Gender, HIV Transmission and Vaccines
Women, HIV Risk and Vaccines in a Rural African Community
Vaccine Briefs
  - Vol. 5 (7), Apr. - Jun. 2001. A global health fund: One step closer
U N Draft Declaration
Haiti: AIDS Vaccine Trial Begins
AIDS Vaccine Tax Legislation P roposed in U.S. and U.K.
Laying Groundwork for AIDS Vaccines in Developing Countries:
A New Research Center Tackles AIDS Vaccines
Vaccine Briefs
  - Vol. 5 (6), Feb. - Mar. 2001. Keystone Symposium: New vaccine candidates - and a major new
       player
Retrovirus 2001: More Animal Studies, More Promise
Supervised Treatment Interruption and Control of HIV
From The Editor
"The Wayward Search for an AIDS Vaccine"
IAVI Translations
IADS in India
Vaccine Briefs
  - Vol. 5 (5), Dec. 2000 - Jan. 2001. A new generation of T-cell assays comes to vaccine trials
Gates Foundation Pledges "Challenge Grant" to IAVI
Phase I DNA Vaccine Trial Begins in Nairobi
Letter from the Editor
Nigeria Workshop Builds Consensus on HIV Vaccine Action Plan
Perspectives on AIDS Vaccines
Cohorts, Communities and HIV Vaccines: On the Ground in Africa
Vaccine Briefs
2000
  - Vol. 5 (4), Sep. - Nov. 2000. Gallo Meeting features new protection data from primates
The Debate on Tat
New Vaccine Study - A Significant Advance
IAVI Launches Two Vaccine Trials in Oxford
Reports from Durban
NIAID Announces International Vaccine Trial Sites
AIDS Vaccine Work in Europe
Palm Beach Meeting Spotlights Novel Vaccine Designs
IAVI Restructures its SAC
Industry Insider
  - Vol. 5 (3), Jul. - Aug. 2000. Next front in HIV vaccines: Gearing up for large-scale clinical trials
NIAID Launches New HIV Vaccine Trials Network
Other NIAID Intiatives
Viewpoint: Vaccine Access Issues Need Attention Now
Canadian AIDS Meeting Highlights Vaccine Development
Canada Announces C$120 Million Plans to Fight AIDS in Developing
       Countries
African Health Ministers Discuss Strategies to Fight AIDS, Boost
       Vaccine Efforts
HIV Vaccine and Prevention Research and NIAID
UNAIDS Global Estimates
  - Vol. 5 (2), Apr. - Jun. 2000. Paris meeting spotlights renewed focus on antibodies
Enhancing Antibodies: A Concern for HIV Vaccine Trials?
IAVI Task Force on Antibodies
IAVI Launches Project to Develop Oral HIV Vaccinne
Phase II "Prime-Boost" Trial in Brazil, Haiti and Trinidad
Report from 3rd Conference on Vaccine Research
The View from SmithKline
Vaccines, IAVI at Durban
Vaccine Briefs
  - Vol. 5 (1), Jan. - Mar. 2000. Higher profile for AIDS vaccines at retrovirus conference
Therapeutic HIV Vaccines
U.S President Promotes Vaccines
Moving IAVI's Scientific Program Forward
IAVI Launches AAV Project
EU Funds South african Vaccine Efforts
Netherlands Contributes to IAVI
An Interview with Sarah Rowland-Jones
Viewpoint: Research on Live Attenuated Vaccines
Economics of AIDS Vaccines
Industry Insider
Vaccine Briefs
1999
  - Vol. 4 (5), Nov. - Dec. 1999. Researchers increasingly optimistic about prospects for AIDS
       vaccine
South African Initiative Makes First Vaccine Awards
"AIDS in Africa" Meeting
Commonwealth Leaders Urge Support for AIDS Vaccines
European Union Funds AIDS Vaccine Program
An Interview with Norman Letvin
AIDS Vaccines at Gallo Meeting
At a Glance: HIV in Africa
Industry Insider
Vaccine Briefs
  - Vol. 4 (4), Sep. - Oct. 1999. Conducting HIV vaccine trials around the world: what we've learned
       so far
A long, rocky path: an interview with Uganda's Roy Mugerwa
From "guinea pig" fears to Phase II trials
Studying the volunteers:
The ebbs and flows of AIDS vaccine trials
ALVAC Prime Boost Trial Results Announced
PMC's Canarypox Vectors
Viewpoint: Do HIV Clades Really Matter?
AIDS Vaccine Glossary
Vaccine Briefs
  - Vol. 4 (3), Jul. - Aug. 1999.  
  - Vol. 4 (2), Apr. - Jun. 1999 UNAIDS to publish guidelines on ethics of vaccine trials
Gates Gives IAVI US$25 Million
Bangkok Conference Highlights Global Vaccine Issues
Vaccines Still A Side Issue at Retrovirus Conference
Keystone Holds Meeting on HIV Vaccines
World Bank, EC Look to Boost AIDS Vaccine Development
AIDS Vaccines and Biotech Companies
India Launches AIDS Vaccine Program
Vaccine Briefs
  - Vol. 4 (1), Jan. - Mar. 1999. Whole killed AIDS vaccines: time for a closer look
Whole Killed Vaccines for Animal Retroviruses
IAVI Fast-Tracks Two Vaccine Approches
An Interview with Neal Nathanson
OAR Council Reviews Vaccine Effort
London Debate on Live Attenuated AIDS Vaccines
U.S. Army's AIDS Budget Cut
AIDS in Kenya
Industry Insider
Global AIDS Map
Letters to the Editor
Vaccine Briefs
1998
  - Vol. 3 (4), Oct. - Dec. 1998. Geneva overview: Vaccines at the 12th World AIDS Conference
Remembering Mary Lou Clements-Mann
One Trial, Many Opinions
IAVI at Geneva
HIV "Resistant" Individuals May Point to a Vaccine
UNAIDS Ethics Meeting
A Closer Look at Vaccine Trial Participants
Vaccines at the Human Virology Meeting
NIH's AIDS Vaccine Panel Reviews Changes, Vectors
Letters to the Editor
Vaccine Briefs
  - Vol. 3 (3), Jul. - Sep. 1998. HIV DNA vaccines move slowly into human trials
IAVI Launches Scientific Blueprint
The Outlook for Key HIV DNA Vaccine Programs
An Interview with Margaret Liu
AIDS in South Africa
South Africa's Explosive AIDS Epidemic
VaxGen gets Approval for U.S. Efficacy Study
Industry Insider
Vaccine Briefs
  - Vol. 3 (2), Apr. - Jun. 1998. Canary pox HIV vaccine trial set to begin in Uganda
HIV Vaccine Purchase Fund
Vaccines Low on the Agenda at 5th Retrovirus Conference
Using Viral Load in HIV Vaccine Trials
UNAIDS Organizes Meetings on Ethics of HIV Vaccine Trials
An Interview with Patuer Merieux Connaught's Michel Klein
Pastuer Merieux Connaught's HIV Vaccine Pipeline
Palm Springs Meeting on HIV Vaccines
NIAID Meetings on Vectors
Viewpoints: Gender Issues and HIV Vaccines
IAVI in Geneva
  - Vol. 3 (1), Jan. - Mar. 1998. Using recombinant vectors as HIV vaccines
AIDS in Africa Meeting
Vector-based HIV Vaccines (Chart)
The Outlook for Leading Vector-based HIV Vaccines
An Interview with Andrew McMichael
New UNAIDS Estimates on the Global Epidemic
IAVI Research Awards
Appeal for Support
Industry Insider
Vaccine Briefs
1997
  - Vol. 2 (3), Oct. - Dec. 1997. Proposed live HIV vaccine trials face safety, production hurdle
AIDS in Asia Meeting
IAVI on Live Attenuated Vaccines
key Changes at Merck and Chiron
Making the Case for the Live Attenuated Approach
Developing a Different Kind of Live HIV Vaccine
Remebering Princess Diana
IAVI Unveils Website
Letters to the Editor
Vaccine Briefs
  - Vol. 2 (2), Summer 1997. U.S. president calls for AIDS vaccine by 2007
AReport from the Conference on Advances in AIDS Vaccines
HIV Subtypes May be Irrelevant
Report Suggests Goat Virus Neutralizes HIV
An Interview with David Baltimore
AIDS in India
Facts About AIDS in India
Indo-U.S. Meeting on HIV Vaccines
International Call for Action & list of Endorsing Nations
IAVI Update
  - Vol. 2 (1), Winter 1997. Live-attenuated AIDS vaccines: new safety findings reported
Scientific Program Launched
Studying HIV Vaccines in Thailand
ALVAC Trial Moves forward in Uganda
IAVI Issues Report on Intellectual Property Rights
Developing HIV-DNA Vaccines
Baltimore to Head NIH AIDS Vaccine Panel
Leading International Organizations Fund IAVI
The Global AIDS Epidemic: No Place on Earth Untouched
1996
  - Vol. 1 (1), Summer 1996. Why an HIV vaccine is scientifically possible
A View from Uganda
Progress On AIDS Vaccines
Industry Perspective
IAVI Launched
Community Leaders Advise IAVI
The Global Spread of HIV

To read PDF files, your internet browser needs Acrobat Reader.
If you do not have Acrobat Reader, you can download a free copy at the link below:

Get Acrobat Reader

© 2008 International AIDS Vaccine Initiative